Exagen inc., allegheny health network research institute and ahn autoimmunity institute announce collaboration to develop novel patented biomarkers into clinical diagnostic tests

The suite of innovative biomarker assays seeks to further aid clinicians in the diagnosis, prognosis and monitoring of patients with autoimmune diseases the suite of innovative biomarker assays seeks to further aid clinicians in the diagnosis, prognosis and monitoring of patients with autoimmune diseases
XGN Ratings Summary
XGN Quant Ranking